Back
Innovent Biologics Stock Price Chart

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
64
IVBXF
Innovent Biologics
Last Price:
$5.94
Seasonality Move:
19.23%
7 Day Trial
ALL ACCESS PASS
$
7

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is moderately bearish and IVBXF is experiencing slight buying pressure.
Innovent Biologics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.52 | Sell |
20-day SMA: | 6.34 | Sell |
50-day SMA: | 5.81 | Buy |
200-day SMA: | 5.23 | Buy |
8-day EMA: | 6.32 | Sell |
20-day EMA: | 6.28 | Sell |
50-day EMA: | 5.88 | Buy |
200-day EMA: | 5.28 | Buy |
Innovent Biologics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 42.98 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.61 - 6.73) | Sell |
Bollinger Bands (100): | (4.38 - 5.98) | Buy |
Innovent Biologics Technical Analysis
May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Innovent Biologics Stock
Is Innovent Biologics Stock a Buy?
-
Innovent Biologics share price is 5.94 while IVBXF 8-day simple moving average is 6.52, which is a Sell signal.
-
The stock price of IVBXF is 5.94 while Innovent Biologics 20-day SMA is 6.34, which makes it a Sell.
-
Innovent Biologics 50-day simple moving average is 5.81 while IVBXF share price is 5.94, making it a Buy technically.
-
IVBXF stock price is 5.94 and Innovent Biologics 200-day simple moving average is 5.23, creating a Buy signal.
IVBXF Technical Analysis vs Fundamental Analysis
Buy
64
Innovent Biologics (IVBXF)
is a Buy
Is Innovent Biologics a Buy or a Sell?
-
Innovent Biologics stock is rated a BuyThe current Innovent Biologics [IVBXF] share price is $5.94. The Score for IVBXF is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Innovent Biologics Stock Info
Market Cap:
9.7B
Price in USD:
5.94
Share Volume:
0
Innovent Biologics 52-Week Range
52-Week High:
6.88
52-Week Low:
3.91
Buy
64
Innovent Biologics (IVBXF)
is a Buy
Innovent Biologics Share Price Forecast
-
What is the Innovent Biologics stock price today?The Innovent Biologics stock price is 5.94 USD today.
-
Will IVBXF stock go up or go down?Innovent Biologics> share price is forecast to RISE/FALL based on technical indicators
-
Is Innovent Biologics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Innovent Biologics is not overvalued.
Is Innovent Biologics Stock a Buy?
-
Innovent Biologics share price is 5.94 while IVBXF 8-day exponential moving average is 6.32, which is a Sell signal.
-
The stock price of IVBXF is 5.94 while Innovent Biologics 20-day EMA is 6.28, which makes it a Sell.
-
Innovent Biologics 50-day exponential moving average is 5.88 while IVBXF share price is 5.94, making it a Buy technically.
-
IVBXF stock price is 5.94 and Innovent Biologics 200-day simple moving average is 5.28, creating a Buy signal.
Technical Analysis of Innovent Biologics
Should I short Innovent Biologics stock?
-
IVBXF Moving Average Covergence Divergence (MACD) indicator is 0.16, suggesting Innovent Biologics is a Buy
-
Innovent Biologics Relative Strength Index (RSI) is 42.98, which suggest Innovent Biologics is oversold
-
The Bollinger Bands (25) for Innovent Biologics is (5.61 - 6.73), which suggest Innovent Biologics is a Buy
-
The Bollinger Bands (100) for Innovent Biologics is (4.38 - 5.98), which suggest Innovent Biologics is a Buy
* Innovent Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.